Selected article for: "clinical diagnosis and molecular characterization"

Author: Crisci, Carlos D.; Ardusso, Ledit R. F.
Title: A Precision Medicine Approach to Rhinitis Evaluation and Management
  • Cord-id: cr7orldf
  • Document date: 2020_2_21
  • ID: cr7orldf
    Snippet: PURPOSE OF REVIEW: Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. The PM approach focuses on the characterization of different phenotypes and pathogenic pathways in order to allow the selection of specific biomarkers that will be useful in disease management. Rhinitis is a highly prevalent and heterogeneous disease, both in terms of underlying endotypes and clinical presentations. Therefore, to apply the PM principles to the various rhinitis su
    Document: PURPOSE OF REVIEW: Precision medicine (PM) represents a new paradigm in disease diagnosis, prevention, and treatment. The PM approach focuses on the characterization of different phenotypes and pathogenic pathways in order to allow the selection of specific biomarkers that will be useful in disease management. Rhinitis is a highly prevalent and heterogeneous disease, both in terms of underlying endotypes and clinical presentations. Therefore, to apply the PM principles to the various rhinitis subtypes rise as a meaningful strategy to improve evaluation and treatment. RECENT FINDINGS: The technology of recombinant allergens has allowed molecular characterization of IgE reactivity of specific individual components of allergenic extracts. Recently published and ongoing clinical trials based on component resolved diagnosis (CRD) bring more precision to allergen immunotherapy for allergic rhinitis. Monoclonal antibodies against various cytokines involved in inflammatory allergic and nonallergic rhinitis endotypes show promissory results. SUMMARY: Better understanding of pathogenic pathways together with an accurate phenotype classification of patients presented with rhinitis symptoms contributes to point out clinical usefulness of biomarkers and other diagnostic tools, which leads to more accurate environmental control measures, personalized pharmacologic options, and new biological therapy developments.

    Search related documents:
    Co phrase search for related documents
    • absence presence and ace inhibitor: 1
    • absence presence and active participation: 1
    • absence presence and acute onset: 1, 2
    • absence presence and acute rhinosinusitis: 1
    • absence presence and additional cytokine: 1
    • absence presence and local inflammation: 1, 2
    • accurate diagnosis and active control: 1
    • accurate diagnosis and acute onset: 1, 2
    • accurate diagnosis and acute rhinosinusitis: 1, 2
    • ace inhibitor and acute onset: 1
    • acute onset and local inflammation: 1
    • acute rhinosinusitis and local allergic rhinitis: 1